Does Ozempic make you tired? Fatigue in the GLP-1 labels
The short answer
Does Ozempic make you tired? Its label names fatigue as a reaction reported at a frequency above 0.4%, outside its main table and with no rate by dose. Five GLP-1 labels list fatigue in their tables: Wegovy (11% of adults on 2.4 mg against 5% on placebo), Zepbound (5% to 7% against 3%), Foundayo, Saxenda and Trulicity. Mounjaro's mentions it outside its main table, and the Rybelsus table doesn't list it.
Key takeaways
- Five GLP-1 labels list fatigue in their tables. Ozempic's and Mounjaro's mention it elsewhere, and the Rybelsus table doesn't list it.
- Contact your prescriber sooner if tiredness is severe, sudden, or comes with vomiting, diarrhea, dizziness or fainting.
- Mention mild, steady fatigue at your next contact.
- Only the Saxenda label says when fatigue tends to happen: mainly within the first 12 weeks of treatment.
- Don't change your dose yourself because of tiredness.
How often it was reported in the label's trials
| Reaction | Placebon=958 | 5 mgn=630 | 10 mgn=948 | 15 mgn=941 |
|---|---|---|---|---|
| Fatigue | 3% | 5% | 6% | 7% |
| Reaction | Placebon=1261 | Wegovy injection 2.4 mg once weeklyn=2116 |
|---|---|---|
| Fatigue | 5% | 11% |
| Reaction | Placebon=303 | Wegovy injection 2.4 mg once weeklyn=304 | Wegovy injection 7.2 mg once weeklyn=1311 |
|---|---|---|---|
| Fatigue | 5% | 9% | 11% |
| Reaction | Placebon=1576 | 5.5 mgn=1051 | 9 mgn=1055 | 17.2 mgn=1049 |
|---|---|---|---|---|
| Fatigue | 4% | 6% | 7% | 9% |
| Reaction | Placebon=1941 | Saxendan=3384 |
|---|---|---|
| Fatigue | 4.6% | 7.5% |
| Reaction | Placebon=126 | Saxendan=125 |
|---|---|---|
| Fatigue | 3.2% | 4.8% |
| Reaction | Placebon=568 | 0.75 mgn=836 | 1.5 mgn=834 |
|---|---|---|---|
| Fatigue | 2.6% | 4.2% | 5.6% |
Each medicine's figures come from its own trials, which differ in dose, length and who took part. They are not a head-to-head comparison.
Feeling tired on a GLP-1? Mention it at your next contact with your prescriber if it’s mild and steady. Contact them sooner if it’s severe, if it came on suddenly, if it follows a dose increase and doesn’t ease, or if it comes with vomiting, diarrhea, dizziness or fainting.
Fatigue is one of the few common reactions in the GLP-1 labels that isn’t a stomach or bowel symptom. The labels treat it unevenly: five give it a table row, two mention it elsewhere and one doesn’t list it.
The five labels with fatigue in their tables
Each figure is the share of trial patients who reported fatigue, next to the placebo group from the same trials. A placebo group gets an inactive treatment instead of the medicine.
- Wegovy 2.4 mg injection (adults, three weight reduction trials): 11%, with 5% on placebo. The label counts fatigue as a grouped term that takes in related reports. In the 7.2 mg trials in adults with obesity: 11% on 7.2 mg, 9% on 2.4 mg and 5% on placebo.
- Foundayo (adults with obesity or overweight, two pooled trials): 6% at 5.5 mg, 7% at 9 mg and 9% at 17.2 mg, with 4% on placebo.
- Saxenda (adults, five trials): 7.5%, with 4.6% on placebo. The same table has a separate row for asthenia, meaning weakness: 2.1%, with 0.8% on placebo.
- Zepbound (adults with obesity or overweight, two pooled trials): 5% at 5 mg, 6% at 10 mg and 7% at 15 mg, with 3% on placebo.
- Trulicity (adults with type 2 diabetes, pooled trials): 4.2% at 0.75 mg and 5.6% at 1.5 mg, with 2.6% on placebo.
In adolescents aged 12 and older with obesity, the Saxenda label reports fatigue in 4.8% on Saxenda and 3.2% on placebo. Fatigue isn’t listed in the Wegovy label’s adolescent table.
In every one of these rows the placebo group reported fatigue too, at between 2.6% and 5%. The gap between the treated and placebo figures runs from under two to six percentage points. The trials are separate and count the term differently, so each gap describes a medicine against its own placebo group, not against the others.
The three labels without a table row
Ozempic. The injection label’s table stops at reactions reported by at least 5% of patients, and fatigue isn’t listed in it. The label’s text says: “Other adverse reactions with a frequency of >0.4% were associated with OZEMPIC include fatigue, dysgeusia and dizziness.” Dysgeusia means taste changes. No rate by dose is given.
Mounjaro. Fatigue isn’t listed in the label’s main table from its placebo-controlled trials. It appears in the description of the cardiovascular outcomes trial in 6,647 adults with type 2 diabetes and established cardiovascular disease, where the label reports fatigue in 10% of patients on Mounjaro.
Rybelsus. Fatigue isn’t listed in the table of the label, which also covers Ozempic tablets.
When does fatigue occur?
One label answers. Saxenda’s says: “Events of asthenia, fatigue, malaise, dysgeusia and dizziness were mainly reported within the first 12 weeks of treatment with SAXENDA and were often co-reported with gastrointestinal events such as nausea, vomiting, and diarrhea.”
Two things follow for Saxenda specifically. The reports clustered early, and tiredness often arrived together with stomach reactions. The label doesn’t say one caused the other.
Related warnings
No warning in our records names fatigue as a symptom. Two warnings are worth knowing about because of what often travels with it:
- Dehydration. Each label warns of acute kidney injury due to volume depletion (losing too much fluid), with most reported cases in patients whose nausea, vomiting or diarrhea led to dehydration. If tiredness comes with vomiting or diarrhea, report both.
- Hypoglycemia. Each label warns that low blood sugar is more likely when the medicine is used with insulin or a sulfonylurea, a type of diabetes pill. The Wegovy, Zepbound and Foundayo labels state plainly that the medicine lowers blood glucose and can cause hypoglycemia. Ask your prescriber or pharmacist what to watch for if you take those medicines.
The Zepbound, Foundayo, Wegovy and Saxenda labels also report low blood pressure in their trials. In Zepbound’s pooled trials, hypotension (low blood pressure) occurred in 1.6% of treated patients and 0.1% on placebo.
When to contact your prescriber
Mention fatigue at your next contact if it’s mild and steady. Contact your prescriber sooner if it’s severe, if it appeared suddenly, if it follows a dose increase and doesn’t ease, or if it comes with vomiting, diarrhea, dizziness or fainting. They can check for causes that have nothing to do with the medicine and decide whether anything about your dose should change. Don’t change it yourself.
Related pages: headache, nausea and the side effects overview.
Frequently asked questions
Does Ozempic make you tired?
The Ozempic injection label doesn't put fatigue in its main table, which only lists reactions reported by at least 5% of patients. It names fatigue separately, saying fatigue, dysgeusia (taste changes) and dizziness were other reactions linked to Ozempic at a frequency above 0.4%. It gives no figure by dose and no placebo comparison for fatigue.
Does Zepbound cause fatigue?
Yes, fatigue is in the Zepbound label's table. In two pooled weight reduction trials in adults with obesity or overweight, 5% of patients on 5 mg, 6% on 10 mg and 7% on 15 mg reported it, compared with 3% on placebo. The label doesn't say when fatigue occurred or how long it lasted.
How long does GLP-1 fatigue last?
Only the Saxenda label addresses timing. It says asthenia (weakness), fatigue, malaise (feeling generally unwell), taste changes and dizziness were mainly reported within the first 12 weeks of treatment. It adds that they were often reported along with stomach and bowel events such as nausea, vomiting and diarrhea. No label says how long your own tiredness will last.
Is tiredness on a GLP-1 a sign of something serious?
The labels warn about dehydration from vomiting or diarrhea, and about low blood sugar when these medicines are used with insulin or a sulfonylurea. Tiredness that's severe, sudden or comes with other symptoms is a reason to contact your prescriber, who can check for a cause. That includes extreme fatigue you can't explain.
Does Wegovy make you tired?
Yes, fatigue is in the Wegovy label's table. In three weight reduction trials of the 2.4 mg injection in adults, 11% of patients reported it, compared with 5% on placebo. The label counts fatigue as a grouped term that takes in related reports. In the 7.2 mg trials, it was reported by 11% on 7.2 mg, 9% on 2.4 mg and 5% on placebo.
Sources (8)
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
Related pages
- GLP-1 side effects: what the FDA labels report
- Headache on Wegovy, Saxenda, Foundayo and other GLP-1 medicines
- Ozempic nausea, Zepbound nausea and the other GLP-1 labels
- Does Ozempic cause hair loss? What the GLP-1 labels report
- Injection site reactions on Zepbound, Saxenda, Wegovy and other GLP-1 injections
- Vomiting on Wegovy, Zepbound, Ozempic and other GLP-1 medicines
